Is hair loss a side effect of Adderall?

0
35

Adderall is a combination drug for the short-term treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Although it is generally a safe and effective drug, it can cause a range of side effects. Alopecia, or hair loss, is a potential but uncommon side effect of taking Adderall. Learn more here.

Related Links:

CORONAVIRUS UK: COVID symptoms include a high fever, a new cough, and loss of smell and taste. But you could also be at risk of COVID-19 infection if you develop a subtle change to your hair. Could your hair loss be caused by coronavirus? Should you consider self-isolating with coronavirus symptoms?

Authors: Makrantonaki E, Zouboulis CC
Abstract
Hyperandrogenism or hyperandrogenemia are medical conditions characterized by excessive levels of androgens in the periphery or systemically. Clinical manifestations of hyperandrogenism include hirsutism, seborrhea, acne, androgenetic alopecia, and virilization. Hirsutism, defined as excessive growth of terminal hair in women in a male-like pattern, is the most commonly used clinical diagnostic criterion of hyperandrogenism and is determined by using a standardized scoring system of hair growth. Acne and alopecia are further common androgenic skin changes and…

An excerpt from This Is Your Brain on Food: An Indispensable Guide to the Surprising Foods that Fight Depression, Anxiety, PTSD, OCD, ADHD, and More. Suzy was a bright and hardworking student. However, even though she was conscientious and generally cheery, her grades began to fall during her senior year, and she started to feel […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.

Source: Kevin, M.D. – Medical WeblogCategory: General Medicine Authors: Tags: Conditions Nutrition Psychiatry Source Type: blogs

Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter,
please visit:
https://www.fightaging.org/newsletter/



Longevity Industry Consulting Services



Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out m…

Source: Fight Aging!Category: Research Authors: Tags: Newsletters Source Type: blogs

HAIR loss can be soul-crushing because it is hard to hide and often becomes more prominent with every passing day. If you are experiencing hair loss, a natural shampoo has yielded encouraging results.

Publication date: November 2020Source: Infant Behavior and Development, Volume 61Author(s): Monique Moore Hill, Devon Gangi, Meghan Miller, Sabrina Mohamed Rafi, Sally Ozonoff

PMID: 32855146 [PubMed – in process]

CONCLUSION: The results of current study showed that in patients with advanced gastric adenocarcinoma, FOLFOX regimen compared to mDCF regimen have similar ORR, OS and PFS. Toxicity rate are also lower in FOLFOX group, thus it seems a better regimen for chemotherapy..
PMID: 32856863 [PubMed – as supplied by publisher]

Conclusion: Patients have seen statistically significant improvements in their ADHD symptomatology in the classroom environment, health related quality of life, and their overall behavior in comparison to placebo, atomoxetine, and OROS-MPH. However, clinical judgment should be utilized when prescribing LDX due to patient specific needs and the side effect profile.
PMID: 32845786 [PubMed – as supplied by publisher]

AbstractA β aggregation is one of the pathological biomarkers of Alzheimer’s disease (AD). However, the possible mechanism related to Aβ-induced pathological signaling pathway is still unknown. In the present study, Aβ1–42-induced time-dependent memory impairment and its possible relationship to hypoth alamic-pituitary-adrenal (HPA) axis hyperactivity were examined. Aβ1–42-treated mice significantly impaired acquisition activity in the learning curve at 10 days, 1 and 4 months in the Morris water-maze (MWM) task. This learning activity was back to normal at 8 months afte…

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here